Frank Mottola sold $623K of Supernus Pharmaceuticals (SUPN)

Executed Aug 25 2025, disclosed Aug 27 2025, 2 days later.

Value, as filed

$623K

14,000 sh × $44.51

Executed

Aug 25 2025

the trade date, as filed

Disclosed

Aug 27 2025

2 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

FM Frank Mottola SVP, Quality, GMP, Ops, IT profile →

Frank Mottola (SVP, Quality, GMP, Ops, IT) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in SUPN. The largest single filing was $1.0M of SUPN (20,000 sh across 2 lots, as filed), executed Dec 19 2025.

The name

SUPN SUPN SUPN · 38 filings in 24 months ticker → Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Frank Mottola in SUPN

SUPNSALE SUPERNUS PHARMACEUTICALS, INC. $1.0M
20,000 sh across 2 lots
Exec Dec 19 2025
Filed Dec 22 2025 · 5:30 PM ET SUPNSALE SUPERNUS PHARMACEUTICALS, INC. $229K
5,000 sh × $45.87
Exec Sep 12 2025
Filed Sep 15 2025 · 5:30 PM ET SUPNSALE SUPERNUS PHARMACEUTICALS, INC. $555K
15,000 sh × $36.98
Exec Nov 7 2024
Filed Nov 8 2024 · 5:30 PM ET